Q1 2023 Aytu Biopharma Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Aytu Biopharma Fiscal 2023 Q1 Results Call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Roger Weiss. Sir, the floor is yours.
Thank you very much. Good afternoon everyone and thank you for joining us for Aytu Biopharma's First Quarter Fiscal Year 2023 Financial Results Conference Call. Joining us on today's call is Aytu's CEO, Josh Disbrow; and this company's Chief Financial Officer, Mark Oki.
At the conclusion of today's prepared remarks, we'll open the call for a question-and-answer session. I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the earnings press release issued earlier today. Finally, I'd also like to call to your attention the customary safe harbor disclosure regarding future-looking information. The conference call today will contain certain
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
